Reversing Glucose and Lipid-mediated Vascular Dysfunction
University of Kansas Medical Center · NCT04832009
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–79 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 46
- US sites recruiting
- 1
- Study start
- May 9, 2022
- Record last updated
- June 5, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.
Being studied: Dextrose 20 % in 500 ML Injection; Intralipid; Saline; Ascorbic acid
Conditions: Blood Pressure; Hypertension
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Lean: BMI \< 25 kg/m
- Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood)
- Middle-aged: 18-79 years
- Blood pressure: \< 140 (systolic) and \< 90 mmHg (diastolic
- Weight stable (+/- 5 lbs) for the previous 3 months
- Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior.
- Able and willing to provide written informed consent
Exclusion Criteria
- Diabetes mellitus Type I or Type II: fasting glucose \< 126 mg/dL and/or HbA1c \< 6.5%
- Current smoker or History of smoking in the past 3 months.
- Hyperlipidemia: Fasting triglycerides \< 250 mg/dL
- Hypertension: >130/80 mmHg
- History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy)
- History of vascular disease (e.g., bypass, stroke)
Recruiting US locations
University of Kansas Medical Center
Kansas City, KS 66103
Site contact: Seth W. W Holwerda · 9729223230 · sholwerda@kumc.edu
Study contacts (from the official record)
- Seth W Holwerda, PhD · 9729223230 · sholwerda@kumc.edu
- Davina A Clonch · 9132266009 · shoggirl@gmail.com
Similar studies in Kansas
All heart & blood pressure studies in Kansas →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Kansas City, KS + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Antidote Therapeutics, Inc
- Location
- Overland Park, KS
- Eligibility basics
- Ages 23–59
- RecruitingHealthy volunteersPhase 1
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Mario Castro, MD, MPH
- Location
- Kansas City, KS
- Eligibility basics
- Ages 3+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Kansas City, KS + 64 other US sites
- Eligibility basics
- Ages 18+